Basse C, Chabanol H, Bonte PE, Fromantin I, et al. Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach. Lung Cancer 2022;173:116-123.
PMID: 36198244